Resources  /  Treatments

Side effects of GLP-1 medicines and how they are managed

Mostly the gut, mostly early. The nausea is the same mechanism as the effect, felt as a symptom.

Educational — not a recommendation to take anything

Mostly the gut, mostly early, mostly manageable

The common adverse effects of GLP‑1 medicines are gastrointestinal, and they follow from how the medicines work rather than being incidental to it. These drugs slow stomach emptying and act on brain regions involved in appetite and nausea. Slower emptying and reduced appetite are the intended effects; nausea is the same mechanism felt as a symptom.

This page describes what is reported and how it is managed clinically. It is not instructions, and nothing here should be used to adjust a prescription.

What is common

From the trial data and product information for this class:

  • Nausea — the commonest, usually worst after a dose increase and easing over subsequent weeks
  • Vomiting
  • Diarrhoea
  • Constipation — frequently under‑mentioned and a common reason people stop
  • Abdominal pain, bloating, reflux
  • Injection site reactions, usually minor
  • Fatigue, headache, and a degree of food aversion

Most are mild to moderate and settle. They are also the main reason people discontinue, which is why the titration schedule exists.

Why the dose goes up slowly

Every agent in this class starts well below its therapeutic dose and increases in steps over weeks. That schedule is not caution for its own sake — it is the single most effective tool for limiting side effects, by letting the gut adapt between increases.

Going up faster than the schedule reliably produces more nausea. Where someone is struggling, holding at the current dose for longer before the next step is a standard clinical response, and a dose reduction is another. Both are decisions for the prescriber.

What is managed, and how

The usual clinical measures, described here so you know what to expect from a competent prescriber rather than so you can self‑manage:

  • Smaller portions, eaten more slowly. The stomach is emptying more slowly; a normal-sized meal behaves like a large one.
  • Stopping at the first sense of fullness. Most nausea reported is from eating past a signal that arrived earlier than usual.
  • Reducing fat and very large meals, which empty slowest.
  • Fluid and fibre for constipation, addressed early rather than when it is entrenched.
  • Adequate protein and resistance training, because weight lost rapidly includes muscle, and that matters for what happens afterwards.

What needs medical attention rather than management

A short list, and the reason a prescription without follow‑up is inadequate:

  • Severe, persistent abdominal pain, particularly radiating to the back — pancreatitis is uncommon but recognised, and is a stop‑and‑seek‑care symptom
  • Persistent vomiting with signs of dehydration, which also risks kidney injury
  • Right upper abdominal pain — gallbladder disease occurs more often with rapid weight loss
  • Visual changes in someone with diabetic retinopathy, where rapid improvement in glucose can worsen it temporarily
  • Signs of low blood sugar, which is uncommon with these alone but more likely alongside insulin or sulfonylureas

Two things that matter beyond symptoms

Anaesthesia. Delayed gastric emptying means the stomach may not be empty after a standard fast. Anaesthesia bodies have issued guidance on this and recommendations have evolved. Tell any anaesthetist or surgeon that you are taking one of these, well before a procedure. It is the single most important practical point on this page.

Other medicines. Slower emptying can affect how other oral drugs are absorbed. Worth a specific conversation if you take anything where timing matters.

Muscle, and why it is not a side effect but is a problem

Rapid weight loss from any cause includes lean tissue as well as fat. The proportion varies, and losing muscle matters because it lowers resting energy expenditure — which is part of why weight returns when treatment stops.

Protein intake and resistance training during treatment are the standard countermeasures. A clinic that prescribes and does not raise this is managing a number rather than a person.

The boundary

None of this tells you whether to start, continue or stop anything. Side effects are a conversation with the prescriber who wrote the prescription — which presumes there is one, that they are contactable, and that follow‑up was part of what you were sold.

Measure it rather than guess

Every patient starts the same way: thirty minutes with a physician, then a full biomarker panel drawn at a laboratory near you. Whether any medicine follows is your doctor’s decision, made after reading your results with you.

Measure my biomarkers